Correction: Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
Nature Communications 6, Article number: 7956 (2015); Published 3 August 2015; Updated 5 February 2016 After reanalysing the RNA sequencing data presented in Supplementary Data 3 of this Article, we have discovered that 341,056 of the 730,620 expression values were inadvertently paired with incorrec...
Guardado en:
Autores principales: | D. M. Janzen, E. Tiourin, J. A. Salehi, D. Y. Paik, J. Lu, M. Pellegrini, S. Memarzadeh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7add917a641249339981b6d80827780a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
por: D. M. Janzen, et al.
Publicado: (2020) -
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
por: Hyoung Kim, et al.
Publicado: (2020) -
Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
por: V. La, et al.
Publicado: (2017) -
Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
por: V. La, et al.
Publicado: (2021) -
The expression of miRNAs is associated with tumour genome instability and predicts the outcome of ovarian cancer patients treated with platinum agents
por: Tianzhen Wang, et al.
Publicado: (2017)